SCHEMBL10277633

SCHEMBL10277633

CCOP(=O)(OCC)C(F)(F)CCOCCOc1ccc(CC2=C(C)CC(C)(N)C(S(=O)(=O)O)C2(C)c2ccnc(C)n2)c(OC)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10090896 0.70 TLR7 (0.40)
SCHEMBL10277635 0.68 TLR7 (0.36)
SCHEMBL160441 0.66 TLR7 (0.35)
SCHEMBL160224 0.64 ALDH1A1 (0.44)
SCHEMBL10277355 0.60 CYP1A1 (0.39)
SCHEMBL10277413 0.54 ALDH1A1 (0.47)
Hydrochloric Acid SCHEMBL2418902 0.52 PNP (0.34)
SCHEMBL13634514 0.51 L3MBTL1 (0.47)
Hydrochloric Acid SCHEMBL2418163 0.50 PNP (0.34)
SCHEMBL22261696 0.48 RARB (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315530-B2 Adsorption of immunopotentiators to insoluble metal salts NOVARTIS AG (CH) 2016-04-19 US disclosed
US-20130274465-A1 ADSORPTION OF IMMUNOPOTENTIATORS TO INSOLUBLE METAL SALTS IRM LLC (BM) 2013-10-17 US disclosed
US-20120177681-A1 Formulation of immunopotentiators GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2012-07-12 US disclosed